| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.058 | 0.7 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |